Gene · 5029
Papers2,260
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,260
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Activation of Purinergic P2Y2 Receptor Protects the Kidney Against Renal Ischemia and Reperfusion Injury in Mice. | Int J Mol Sci | 2024 | 39684275 | PubTator, text mining | PubMed |
| G protein coupled P2Y2 receptor as a regulatory molecule in cancer progression. | Arch Biochem Biophys | 2024 | 39486566 | PubTator, text mining | PubMed |
| Sports-Related Genomic Predictors Are Associated with Athlete Status in Chinese Sprint/Power Athletes. | Genes (Basel) | 2024 | 39457375 | PubTator, text mining | PubMed |
| Adenosine diphosphate released from stressed cells triggers mitochondrial transfer to achieve tissue homeostasis. | PLoS Biol | 2024 | 39163396 | PubTator, text mining | PubMed |
| PM2.5 Exposure Inhibits Transepithelial Anion Short-circuit Current by Downregulating P2Y2 Receptor/CFTR Pathway. | Int J Med Sci | 2024 | 39113893 | PubTator, text mining | PubMed |
| Design, Synthesis, and Evaluation of a New Chemotype Fluorescent Ligand for the P2Y2 Receptor. | ACS Med Chem Lett | 2024 | 39015271 | PubTator, text mining | PubMed |
| Identification of exosomal microRNAs and related hub genes associated with imatinib resistance in chronic myeloid leukemia. | Naunyn Schmiedebergs Arch Pharmacol | 2024 | 38916832 | PubTator, text mining | PubMed |
| Basal ATP release signals through the P2Y2 receptor to maintain the differentiated phenotype of vascular smooth muscle cells. | Atherosclerosis | 2024 | 38889566 | PubTator, text mining | PubMed |
| Double-modified, thio and methylene ATP analogue facilitates wound healing in vitro and in vivo. | Sci Rep | 2024 | 38849425 | PubTator, text mining | PubMed |
| P2Y2R and Cyst Growth in Polycystic Kidney Disease. | J Am Soc Nephrol | 2024 | 38848134 | PubTator, text mining | PubMed |
| Assessment of NLRP3 inflammasome activation in patients with chronic obstructive pulmonary disease before and after lung transplantation. | Immunol Res | 2024 | 38811459 | PubTator, text mining | PubMed |
| Metastasis and angiogenesis in cervical cancer: key aspects of purinergic signaling in platelets and possible therapeutic targets. | Purinergic Signal | 2024 | 38753131 | PubTator, text mining | PubMed |
| Sex-dependent regulation of mucin gene transcription and airway secretion and mechanics following intra-airway IL-13 in mice with conditional loss of club cell Creb1. | Front Physiol | 2024 | 38711951 | PubTator, text mining | PubMed |
| Pulmonary Ionocytes: What Are They Transporting and Which Way? | Am J Respir Crit Care Med | 2024 | 38701428 | PubTator, text mining | PubMed |
| Gene expression alterations of purinergic signaling components in obesity-associated intestinal low-grade inflammation in type 2 diabetes. | Purinergic Signal | 2024 | 38587723 | PubTator, text mining | PubMed |
| Combining WGCNA and machine learning to identify mechanisms and biomarkers of ischemic heart failure development after acute myocardial infarction. | Heliyon | 2024 | 38455553 | PubTator, text mining | PubMed |
| Not just sugar: metabolic control of neutrophil development and effector functions. | J Leukoc Biol | 2024 | 38450755 | PubTator, text mining | PubMed |
| Cytokine storm in human monkeypox: A possible involvement of purinergic signaling. | Cytokine | 2024 | 38447385 | PubTator, text mining | PubMed |
| SARS-CoV-2 spike protein receptor binding domain promotes IL-6 and IL-8 release via ATP/P2Y2 and ERK1/2 signaling pathways in human bronchial epithelia. | Mol Immunol | 2024 | 38359646 | PubTator, text mining | PubMed |
| Pro-inflammatory cytokines stimulate CFTR-dependent anion secretion in pancreatic ductal epithelium. | Cell Mol Biol Lett | 2024 | 38262945 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5029/papers?page=4